Elanco director receives equity awards in stock units

Harrington Michael J reported acquisition or exercise transactions in this Form 4 filing.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Harrington Michael J reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health director Michael J. Harrington reported equity awards of common stock on May 21, 2026. He received 12,196 deferred stock units as a pro-rated annual equity award and 4,678 restricted stock units as an annual equity award for non-employee board members, both at no cash cost.

Insider Trade Summary

Grant/Award: 16,874 shares

Grant/Award 2 txns

Insider Harrington Michael J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,678	$0.00	$0.00
Grant/Award	Common Stock	12,196	$0.00	$0.00

Holdings After Transaction: Common Stock — 126,451 shares (Direct)

Footnotes (2)

F1. Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.
F2. Grant of restricted stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Key Figures

Deferred stock units granted: 12,196 units Restricted stock units granted: 4,678 units Shares held after DSU grant: 126,451 shares +1 more

4 metrics

Deferred stock units granted 12,196 units Pro-rated annual equity award to non-employee director on May 21, 2026

Restricted stock units granted 4,678 units Annual equity award to non-employee director on May 21, 2026

Shares held after DSU grant 126,451 shares Common stock directly owned after 12,196-unit grant

Shares held after RSU grant 114,255 shares Common stock directly owned after 4,678-unit grant

Key Terms

deferred stock units, restricted stock units, non-employee members of the Issuer's Board of Directors

3 terms

deferred stock units financial

"Grant of deferred stock units as a pro-rated annual equity award"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

restricted stock units financial

"Grant of restricted stock units as an annual equity award"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

non-employee members of the Issuer's Board of Directors financial

"annual equity award to each of the non-employee members of the Issuer's Board of Directors"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Elanco (ELAN) director Michael J. Harrington report in this Form 4?

He reported receiving equity awards of Elanco common stock. The awards consisted of deferred stock units and restricted stock units granted as part of his annual compensation for serving as a non-employee member of the Board of Directors.

How many Elanco (ELAN) deferred stock units did Michael J. Harrington receive?

He received 12,196 deferred stock units. These units were granted as a pro-rated annual equity award provided to each non-employee member of Elanco’s Board of Directors as part of their standard board compensation program.

How many Elanco (ELAN) restricted stock units were granted to Michael J. Harrington?

He was granted 4,678 restricted stock units. This grant represents the regular annual equity award made to each non-employee director serving on Elanco’s Board of Directors, and it was reported as a stock-based compensation transaction.

Did Michael J. Harrington buy or sell Elanco (ELAN) shares on the market?

No market purchases or sales were reported. The Form 4 shows only stock-based compensation grants, with no open-market buy or sell transactions and no cash changing hands for the reported equity awards.

What were Michael J. Harrington’s Elanco (ELAN) holdings after these grants?

One line shows 126,451 shares of common stock held after a 12,196-unit grant, and another shows 114,255 shares after a 4,678-unit grant, reflecting updated direct ownership positions following the separate equity awards.

Why did Elanco (ELAN) grant deferred and restricted stock units to its director?

The deferred stock units and restricted stock units were granted as annual equity awards. These awards are part of the compensation program for non-employee members of Elanco’s Board of Directors, aligning director pay with the company’s stock performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/26/2026 - 04:44 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Harrington Michael J

(Last)

(First)

(Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS

INDIANA

46221

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/21/2026		A		4,678⁽¹⁾	A	$0	114,255	D
Common Stock	05/21/2026		A		12,196⁽²⁾	A	$0	126,451	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.

2. Grant of restricted stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Michael J. Harrington	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR